155 related articles for article (PubMed ID: 30674935)
1. A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells.
Abou Faycal C; Gazzeri S; Eymin B
Sci Rep; 2019 Jan; 9(1):336. PubMed ID: 30674935
[TBL] [Abstract][Full Text] [Related]
2. The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.
Abou Faycal C; Brambilla E; Agorreta J; Lepeltier N; Jacquet T; Lemaître N; Emadali A; Lucas A; Lacal PM; Montuenga L; Pio R; Gazzeri S; Eymin B
Br J Cancer; 2018 Jun; 118(12):1596-1608. PubMed ID: 29795310
[TBL] [Abstract][Full Text] [Related]
3. FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells.
Jia T; Jacquet T; Dalonneau F; Coudert P; Vaganay E; Exbrayat-Héritier C; Vollaire J; Josserand V; Ruggiero F; Coll JL; Eymin B
BMC Biol; 2021 Aug; 19(1):173. PubMed ID: 34433435
[TBL] [Abstract][Full Text] [Related]
4. Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer.
Zygalaki E; Tsaroucha EG; Kaklamanis L; Lianidou ES
Clin Chem; 2007 Aug; 53(8):1433-9. PubMed ID: 17599955
[TBL] [Abstract][Full Text] [Related]
5. A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.
Wu FT; Stefanini MO; Mac Gabhann F; Popel AS
PLoS One; 2009; 4(4):e5108. PubMed ID: 19352513
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 and granulocyte-macrophage colony-stimulating factor mediates the upregulation of soluble vascular endothelial growth factor receptor-1 in RAW264.7 cells-a process in which p38 mitogen-activated protein kinase signaling has an important role.
Xia L; Dong Z; Zhang Y; Zhang X; Song X; Sun M; Hu Y; Liu S; Wang K; Qu X; Wei F
J Microbiol Immunol Infect; 2016 Jun; 49(3):344-51. PubMed ID: 25132397
[TBL] [Abstract][Full Text] [Related]
7. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
8. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
[TBL] [Abstract][Full Text] [Related]
10. Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Cells; 2019 Jul; 8(7):. PubMed ID: 31295920
[TBL] [Abstract][Full Text] [Related]
11. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
[TBL] [Abstract][Full Text] [Related]
12. SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development.
Luo C; Cheng Y; Liu Y; Chen L; Liu L; Wei N; Xie Z; Wu W; Feng Y
Cancer Res; 2017 Mar; 77(5):1168-1178. PubMed ID: 28082404
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
14. Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.
Wu FT; Stefanini MO; Mac Gabhann F; Kontos CD; Annex BH; Popel AS
Physiol Genomics; 2009 Jun; 38(1):29-41. PubMed ID: 19351908
[TBL] [Abstract][Full Text] [Related]
15. Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3.
Wei Z; Wang Y; Ma W; Xing W; Lu P; Shang Z; Li F; Li H; Wang Y
RNA Biol; 2023 Jan; 20(1):359-367. PubMed ID: 37335045
[TBL] [Abstract][Full Text] [Related]
16. Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
Holzer TR; Fulford AD; Reising LO; Nedderman DM; Zhang X; Benjamin LE; Schade AE; Nasir A
Anticancer Res; 2016 Jul; 36(7):3277-88. PubMed ID: 27354584
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
[TBL] [Abstract][Full Text] [Related]
18. Kif4 regulates the expression of VEGFR1 through the PI3K/Akt signaling pathway in RAW264.7 monocytes/macrophages.
Xu Y; Luan Y; Liu S; Sun J; Wang K; Cai J; Jiang W; Yang P; Wei F; Qu X
Int J Mol Med; 2017 May; 39(5):1285-1290. PubMed ID: 28350061
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cis-acting elements that control oscillating alternative splicing.
Goldammer G; Neumann A; Strauch M; Müller-McNicoll M; Heyd F; Preußner M
RNA Biol; 2018; 15(8):1081-1092. PubMed ID: 30200840
[TBL] [Abstract][Full Text] [Related]
20. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.
Toi M; Bando H; Ogawa T; Muta M; Hornig C; Weich HA
Int J Cancer; 2002 Mar; 98(1):14-8. PubMed ID: 11857378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
